HSPB6 expression has been found to be depleted in ovarian cancer [20] and colorectal cancer [21], and its presence drives HCT116 cells to undergo apoptosis events by inducing caspase 3/7 expression and inhibiting BCL2 expression [21]. This evidence concerns the gene HSPB6 and ovarian cancer.